• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓灰质炎病毒的胍抗性缺陷干扰颗粒

Guanidine-resistant defective interfering particles of poliovirus.

作者信息

Tershak D R

出版信息

J Virol. 1982 Feb;41(2):615-25. doi: 10.1128/JVI.41.2.615-625.1982.

DOI:10.1128/JVI.41.2.615-625.1982
PMID:6281472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC256790/
Abstract

A mixture containing standard poliovirus and D3 particles (mutants with deletions in the capsid locus) was serially passaged in the presence of guanidine. Within five growth cycles, the standard virus was guanidine resistant, but the D3 particles were guanidine sensitive, even after 21 passages with the inhibitor. By passage 40 with guanidine, D3 particles were eliminated, and a new deletion mutant (DX) appeared in the virus population. D3 particles contained a 15% deletion, and DX particles contained a 6% deletion in the capsid locus. Although neither mutant induced the synthesis of NCVP1a or a complete complement of capsid proteins after infection, cells infected with DX particles produced two novel proteins, which had molecular weights of approximately 68,000 and 25,000.

摘要

含有标准脊髓灰质炎病毒和D3颗粒(衣壳基因座有缺失的突变体)的混合物在胍存在的情况下连续传代。在五个生长周期内,标准病毒对胍具有抗性,但D3颗粒对胍敏感,即使在用该抑制剂传代21次后仍是如此。到用胍传代40次时,D3颗粒被消除,并且在病毒群体中出现了一种新的缺失突变体(DX)。D3颗粒在衣壳基因座中有15%的缺失,而DX颗粒在衣壳基因座中有6%的缺失。尽管这两种突变体在感染后均未诱导非衣壳病毒蛋白1a(NCVP1a)的合成或衣壳蛋白的完整互补,但用DX颗粒感染的细胞产生了两种新蛋白,其分子量约为68,000和25,000。

相似文献

1
Guanidine-resistant defective interfering particles of poliovirus.脊髓灰质炎病毒的胍抗性缺陷干扰颗粒
J Virol. 1982 Feb;41(2):615-25. doi: 10.1128/JVI.41.2.615-625.1982.
2
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C.脊髓灰质炎病毒的胍选择突变体:点突变定位到多肽2C
J Virol. 1986 Feb;57(2):638-46. doi: 10.1128/JVI.57.2.638-646.1986.
3
Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.一种重组痘苗病毒对脊髓灰质炎病毒缺陷基因组的互补作用,该重组痘苗病毒在反式作用下提供脊髓灰质炎病毒P1衣壳前体。
J Virol. 1993 Jun;67(6):3684-90. doi: 10.1128/JVI.67.6.3684-3690.1993.
4
Poliovirus coat protein as the site of guanidine action.脊髓灰质炎病毒衣壳蛋白作为胍作用的位点。
Virology. 1977 Aug;81(1):25-36. doi: 10.1016/0042-6822(77)90055-1.
5
Capsid protein precursor is one of two initiated products of translation of poliovirus RNA in vitro.衣壳蛋白前体是脊髓灰质炎病毒RNA在体外翻译的两种起始产物之一。
J Virol. 1979 May;30(2):481-8. doi: 10.1128/JVI.30.2.481-488.1979.
6
Characterization of a new isolate of poliovirus defective interfering particles.一种新型脊髓灰质炎病毒缺陷干扰颗粒分离株的特性分析
Cell. 1979 Nov;18(3):759-69. doi: 10.1016/0092-8674(79)90129-6.
7
Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins.1型脊髓灰质炎病毒马奥尼株和萨宾株的重组体:体外表型标志物分析及对胍抗性定位于非结构蛋白的证据
Virology. 1984 Aug;137(1):74-85. doi: 10.1016/0042-6822(84)90010-2.
8
Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA.脊髓灰质炎病毒在体外的完全复制:起始前RNA复制复合体合成与VPg相连的RNA需要可溶性细胞因子。
J Virol. 1995 Sep;69(9):5516-27. doi: 10.1128/JVI.69.9.5516-5527.1995.
9
In vitro synthesis of poliovirus.脊髓灰质炎病毒的体外合成。
Dev Biol Stand. 1993;78:39-53.
10
Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements.脊髓灰质炎病毒的胍依赖性突变体:具有不同生长需求的三类突变体的鉴定。
Virology. 1987 Mar;157(1):83-8. doi: 10.1016/0042-6822(87)90316-3.

引用本文的文献

1
Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses.吡咯烷二硫代氨基甲酸盐对人鼻病毒的抗病毒作用。
J Virol. 2002 Jun;76(12):6004-15. doi: 10.1128/jvi.76.12.6004-6015.2002.
2
Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins.对胍具有抗性的脊髓灰质炎病毒突变体产生修饰的37千道尔顿蛋白质。
J Virol. 1984 Jun;50(3):922-8. doi: 10.1128/JVI.50.3.922-928.1984.
3
Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants.耐胍盐口蹄疫病毒突变体的重组与寡核苷酸分析

本文引用的文献

1
In vitro inhibition of infectivity of polio viruses by guanidine.胍对脊髓灰质炎病毒传染性的体外抑制作用。
Nature. 1962 Jan 6;193:97-8. doi: 10.1038/193097a0.
2
A GUANIDINE-DEPENDENT VARIANT OF POLIOVIRUS. ISOLATION OF A VARIANT AND SOME OF ITS BIOLOGICAL PROPERTIES.一种依赖胍的脊髓灰质炎病毒变体。变体的分离及其一些生物学特性
Virology. 1963 Oct;21:264-6. doi: 10.1016/0042-6822(63)90266-6.
3
Guanidine conditioned infectivity of ribonucleic acid extracted from a strain of guanidine-dependent polio-1-virus.胍对从一株依赖胍的脊髓灰质炎1型病毒中提取的核糖核酸感染性的影响。
J Virol. 1985 Dec;56(3):921-9. doi: 10.1128/JVI.56.3.921-929.1985.
Nature. 1963 Jan 19;197:315. doi: 10.1038/197315a0.
4
Antiviral effect of guanidine.胍的抗病毒作用。
Science. 1961 Aug 25;134(3478):558-9. doi: 10.1126/science.134.3478.558.
5
Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures.胍对细胞培养中脊髓灰质炎病毒增殖的抑制作用研究。
Virology. 1961 Sep;15:65-74. doi: 10.1016/0042-6822(61)90078-2.
6
Generation of defective interfering particles in picornaviruses.微小核糖核酸病毒中缺陷干扰颗粒的产生。
Virology. 1980 Jan 30;100(2):408-18. doi: 10.1016/0042-6822(80)90532-2.
7
Absence of subviral particles and assembly activity in HeLa cells infected with defective-interfering (DI) particles of poliovirus.感染脊髓灰质炎病毒缺陷干扰(DI)颗粒的HeLa细胞中不存在亚病毒颗粒及组装活性。
Virology. 1980 Jan 15;100(1):116-24. doi: 10.1016/0042-6822(80)90557-7.
8
Inhibition of tobacco necrosis virus by guanidine carbonate.碳酸胍对烟草坏死病毒的抑制作用。
Virology. 1968 Oct;36(2):305-8. doi: 10.1016/0042-6822(68)90149-9.
9
Basis for variable response of arboviruses to guanidine treatment.虫媒病毒对胍治疗反应可变的基础。
J Virol. 1970 Nov;6(5):628-36. doi: 10.1128/JVI.6.5.628-636.1970.
10
Early functions of poliovirus. 3. The effect of guanidine on early functions.脊髓灰质炎病毒的早期功能。3. 胍对早期功能的影响。
Z Naturforsch B. 1971 Sep;26(9):940-4. doi: 10.1515/znb-1971-0917.